HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Interviews

Over The Counter 24 May 2022: US OTC Monograph Reform And A 'Faster Moving FDA’ With CHPA’s Barbara Kochanowski and David Spangler

In this episode, HBW Insight speaks to Barbara Kochanowski and David Spangler of the US Consumer Healthcare Products Association about OTC monograph reform. The OTC monograph program was reimagined as a part of the 2020 CARES act passed in the early stages of the pandemic. While the changes were designed to streamline and modernize the program, results have been slow with the FDA's attention focused on tackling COVID-19. But as the agency hires more staff, Spangler says he expects to see a "faster moving FDA" in the next three years. Spangler and Kochanowski also discuss the efficacy of the monograph reforms and how CHPA has helped educate its members about the changes.

OTC Drugs United States

Over The Counter 9 May 2022: The Landscape Of Naloxone Access With HRT’s Michael Hufford

In this episode, HBW Insight speaks to Michael Hufford, co-founder and CEO of Harm Reduction Therapeutics about the inaccessibility in the US of naloxone, a life-saving opioid overdose antidote. Hufford unpacks the history of naloxone access and explains why standing orders aren’t as helpful as they seem. We also explore the incentives for companies currently producing prescription naloxone to make the switch to OTC status, and why many of them have chosen not to. While the financial incentive may not be there, the public health need is dire, and Hufford explains the importance of harm reduction groups and non-profit pharmaceutical companies for getting naloxone into the hands of those who need it the most.

US States Health

Lockdown Stockpiling May Edge China’s Supplements Market Into Global Top Spot

Chinese consumers are stockpiling dietary supplements again against the backdrop of new coronavirus lockdowns in parts of the country. TMO Group thinks this could edge China into the global number one spot in terms of size, ahead of the US. Managing partner Jing Zhou comments on the trends that have driven China's stellar rise, and how international consumer health firms can seize the country's supplements opportunity.

China Wellness

Over The Counter 3 May 2022: Which COVID Trends Are Here To Stay? With IQVIA Consumer Health’s Prasanna Pitale

In this episode, HBW Insight talks to IQVIA Consumer Health’s Prasanna Pitale about the company's research on the recent self-care trends that will endure after COVID-19. Pitale points to wellness and prevention, Rx-to-OTC switch and naturals as drivers of long-term change in the global consumer health market. Sustainability and artificial intelligence are also noted as important disruptors that OTC companies need to act on if they are stay ahead of the pack in the years ahead.

International Health

Over The Counter 25 Apr 2022: Exploring The Intersection Of Skin Care, AI And Business With Revieve's Sampo Parkkinen

In this episode of Over The Counter, HBW Insight speaks to AI technology expert Sampo Parkkinen, CEO of Revieve, which helps its clients deliver personalized digital brand experiences. We discuss the importance of customization for businesses and consumers, the future of AI in the cosmetics industry, and the younger demographics that are most interested in brand personalization. Parkkinen also comments on Revieve’s space in the metaverse, and how businesses can leverage new technology to build relationships with consumers.

International Beauty

Over The Counter 19 April 2022: Q1 Consumer Health Earnings Preview, With HBW Editors

In this episode, HBW Insight editors look ahead to Q1 sales and earnings reports of the world’s largest consumer healthcare companies. We reflect on what has happened in the last 12 months during the COVID-19 pandemic, and what the next few months might bring for industry. The return of cough and cold, inflation, the war in Ukraine and OTC business spin-offs are all major trends shaping the market right now. 

International Health

Over The Counter 11 April 2022: Sustainability In US And EU Cosmetics With HBW's Ryan Nelson

This episode of the Over The Counter podcast takes a bird’s eye view of sustainability in the cosmetics industry with HBW Insight editor Ryan Nelson. We discuss the drivers of sustainability efforts, such as consumer demand for more eco-friendly products and the growing social consciousness about climate change. How the beauty industry is using third-party regulatory groups to combat greenwashing is also covered, along with steps companies are taking to make their products more sustainable and the legislation in the US and EU that is putting pressure on businesses.

Sustainability Beauty

Arcaea CEO On Biotech’s Promise: Sustainable, Yes, But Ingredient Performance Will Drive Adoption

With biotech, “the entire tree of life starts to become accessible to us ethically and sustainably,” says Arcaea CEO Jasmina Aganovic. Her company, launched in October 2021, is developing custom keratin molecules for skin and hair, as well as new UV filter technology, among other innovations to expand formulators’ toolkits, not just replace problematic ingredients.

Cosmetic Ingredients Business Strategies
See All